Weight-adjusted urinary creatinine excretion predicts transplant outcomes in adult patients with acute myeloid leukemia in complete remission

References

• Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106(8):2912–2919.
   PubMed Web of Science ®Google Scholar
• Shachar SS, Williams GR, Muss HB, et al. Prognostic value of sarcopenia in adults with solid tumours: a Meta-analysis and systematic review. Eur J Cancer. 2016;57:58–67.
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Bahat G, Bauer J, et al.; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised european consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.
   PubMed Web of Science ®Google Scholar
• Nakanishi S, Iwamoto M, Shinohara H, et al. Significance of body mass index for diagnosing sarcopenia is equivalent to slow gait speed in japanese individuals with type 2 diabetes: Cross-sectional study using outpatient clinical data. J Diabetes Investig. 2021;12(3):417–424.
   PubMed Web of Science ®Google Scholar
• Fuji S, Takano K, Mori T, et al. Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT. Bone Marrow Transplant. 2014;49(12):1505–1512.
   PubMed Web of Science ®Google Scholar
• Miyashita E, Konuma T, Kataoka J, et al. The prognostic impact of pretransplantation inflammatory and nutritional status in adult patients after myeloablative single cord blood transplantation. Biol Blood Marrow Transplant. 2019;25(5):981–988.
   PubMed Web of Science ®Google Scholar
• Doney K, McMillen K, Buono L, et al. Impact of body mass index on outcomes of hematopoietic stem cell transplantation in adults. Biol Blood Marrow Transplant. 2019;25(3):613–620.
   PubMedGoogle Scholar
• Gleimer M, Li Y, Chang L, et al. Baseline body mass index among children and adults undergoing allogeneic hematopoietic cell transplantation: clinical characteristics and outcomes. Bone Marrow Transplant. 2015;50(3):402–410.
   PubMed Web of Science ®Google Scholar
• Paviglianiti A, Dalle JH, Ayas M, et al. Low body mass index is associated with increased risk of acute gvhd after umbilical cord blood transplantation in children and young adults with acute leukemia: a study on behalf of eurocord and the EBMT pediatric disease working party. Biol Blood Marrow Transplant. 2018;24(4):799–805.
   PubMed Web of Science ®Google Scholar
• Tai J, Buras M, Leis J, et al. Pretransplant body mass index on outcomes of allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2020;55(6):1175–1177.
   PubMed Web of Science ®Google Scholar
• Konishi T, Doki N, Kishida Y, et al. Geriatric nutritional risk index (GNRI) just before allogeneic hematopoietic stem cell transplantation predicts transplant outcomes in patients older than 50 years with acute myeloid leukemia in complete remission. Ann Hematol. 2019;98(7):1799–1801.
   PubMed Web of Science ®Google Scholar
• Kaito S, Wada A, Adachi H, et al. Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2020;99(7):1655–1665.
   PubMed Web of Science ®Google Scholar
• Sieber CC. Malnutrition and sarcopenia. Aging Clin Exp Res. 2019;31(6):793–798.
   PubMed Web of Science ®Google Scholar
• Sakatoku K, Ito A, Tajima K, et al. Prognostic significance of low pre-transplant skeletal muscle mass on survival outcomes in patients undergoing hematopoietic stem cell transplantation. Int J Hematol. 2020;111(2):267–277.
   PubMed Web of Science ®Google Scholar
• Ando T, Fujisawa S, Teshigawara H, et al. Computed tomography-defined sarcopenia: prognostic predictor of nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study. Int J Hematol. 2020;112(1):46–56.
   PubMed Web of Science ®Google Scholar
• Boutin RD, Yao L, Canter RJ, et al. Sarcopenia: Current concepts and imaging implications. AJR Am J Roentgenol. 2015;205(3):W255–266.
   PubMed Web of Science ®Google Scholar
• Heymsfield SB, Arteaga C, McManus C, et al. Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr. 1983;37(3):478–494.
   PubMed Web of Science ®Google Scholar
• Hessels L, Koopmans N, Gomes Neto AW, et al. Urinary creatinine excretion is related to short-term and long-term mortality in critically ill patients. Intensive Care Med. 2018;44(10):1699–1708.
   PubMed Web of Science ®Google Scholar
• Oterdoom LH, van Ree RM, de Vries AP, et al. Urinary creatinine excretion reflecting muscle mass is a predictor of mortality and graft loss in renal transplant recipients. Transplantation. 2008;86(3):391–398.
   PubMed Web of Science ®Google Scholar
• ter Maaten JM, Damman K, Hillege HL, et al. Creatinine excretion rate, a marker of muscle mass, is related to clinical outcome in patients with chronic systolic heart failure. Clin Res Cardiol. 2014;103(12):976–983.
   PubMed Web of Science ®Google Scholar
• Wilson FP, Xie D, Anderson AH, et al.; the CRIC Study Investigators. Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC study. CJASN. 2014;9(12):2095–2103.
   PubMed Web of Science ®Google Scholar
• Hsu CY, Wu YL, Cheng CY, et al. Low baseline urine creatinine excretion rate predicts poor outcomes among critically ill acute stroke patients. Curr Neurovasc Res. 2015;12(1):47–52.
   PubMed Web of Science ®Google Scholar
• Bouillanne O, Morineau G, Dupont C, et al. Geriatric nutritional risk index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr. 2005;82(4):777–783.
   PubMed Web of Science ®Google Scholar
• Mrozek K, Marcucci G, Nicolet D, et al. Prognostic significance of the european LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia. J Clin Oncol. 2012;30(36):4515–4523.
   PubMed Web of Science ®Google Scholar
• Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15(6):825–828.
   PubMed Web of Science ®Google Scholar
• Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 seattle patients. Am J Med. 1980;69(2):204–217.
   PubMed Web of Science ®Google Scholar
• Konishi T, Doki N, Nagata A, et al. Unmanipulated haploidentical hematopoietic stem cell transplantation using very low-dose antithymocyte globulin and methylprednisolone in adults with relapsed/refractory acute leukemia. Ann Hematol. 2020;99(1):147–155.
   PubMed Web of Science ®Google Scholar
• Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013;48(3):452–458.
   PubMed Web of Science ®Google Scholar
• Yanada M, Konuma T, Mizuno S, et al. Predicting non-relapse mortality following allogeneic hematopoietic cell transplantation during first remission of acute myeloid leukemia. Bone Marrow Transplant. 2021; 56(2): 387–394
   Google Scholar
• Krell RW, Kaul DR, Martin AR, et al. Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation. Liver Transpl. 2013;19(12):1396–1402.
   PubMed Web of Science ®Google Scholar
• Cohen S, Nathan JA, Goldberg AL. Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov. 2015;14(1):58–74.
   PubMed Web of Science ®Google Scholar
• zawa KP, Watanabe S, Oka K, et al. Respiratory muscle strength in relation to sarcopenia in elderly cardiac patients. Aging Clin Exp Res. 2016;28(6):1143–1148.
   PubMed Web of Science ®Google Scholar
• Bourke CD, Berkley JA, Prendergast AJ. Immune dysfunction as a cause and consequence of malnutrition. Trends Immunol. 2016;37(6):386–398.
   PubMed Web of Science ®Google Scholar
• Nardone OM, de Sire R, Petito V, et al. Inflammatory bowel diseases and sarcopenia: the role of inflammation and gut microbiota in the development of muscle failure. Front Immunol. 2021;12:694217.
   PubMed Web of Science ®Google Scholar
• Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol. 2018;14(9):513–537.
   PubMed Web of Science ®Google Scholar
• Ji Y, Cheng B, Xu Z, et al. Impact of sarcopenic obesity on 30-day mortality in critically ill patients with intra-abdominal sepsis. J Crit Care. 2018;46:50–54.
   PubMed Web of Science ®Google Scholar
• Baracos VE, Arribas L. Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy. Ann Oncol. 2018;29(suppl_2):ii1–ii9.
   Web of Science ®Google Scholar
• Lim S, Kim JH, Yoon JW, et al. Sarcopenic obesity: prevalence and association with metabolic syndrome in the korean longitudinal study on health and aging (KLoSHA). Diabetes Care. 2010;33(7):1652–1654.
   PubMed Web of Science ®Google Scholar
• Crispim Carvalho NN, Baccin Martins VJ, Modesto Filho J, et al. Relationship between skeletal muscle mass indexes and muscular function, metabolic profile and bone mineral density in women with recommendation for bariatric surgery. DMSO. 2019;ume 12:2645–2654.
   Google Scholar
• Kim JH, Choi SH, Lim S, et al. Sarcopenia and obesity: gender-differentrelationship with functional limitation in older persons. J Korean Med Sci. 2013;28(7):1041–1047.
   PubMed Web of Science ®Google Scholar